Cargando…

Bowel ulceration following tocilizumab administration in a COVID-19 patient

Tocilizumab, a monoclonal antibody against interleukin-6, has been used to treat cytokine release syndrome (CRS) in a subset of patients with severe COVID-19 disease. Acute ulcerative bowel disease has been only rarely documented in patients treated for rheumatological conditions. The gastrointestin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruce-Hickman, Damian, Sajeed, Shanaz Matthew, Pang, Yin Huei, Seow, Choon Sheong, Chen, Weihao, Gulati Kansal, Monika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437943/ https://www.ncbi.nlm.nih.gov/pubmed/32816957 http://dx.doi.org/10.1136/bmjgast-2020-000484

Ejemplares similares

Case report on a rare cause of small bowel perforation perforated ileal diverticulum
por: Rajaguru, Kishore, et al.
Publicado: (2021)

Case report on a rare cause of silent duodenal perforation
por: Rajaguru, Kishore, et al.
Publicado: (2020)

In-hospital cardiac arrest incidence and outcomes in the era of COVID-19: an observational study in a Singapore hospital
por: Lyu, Ting, et al.
Publicado: (2021)

COVID-19 and the impact on surgical training and education in Singapore
por: Seow, Choon Sheong, et al.
Publicado: (2022)

Tocilizumab: Bowel perforation following off-label use: 2 case reports
Publicado: (2021)

Tocilizumab and COVID-19: Timing of administration assessment
por: Richier, Q., et al.
Publicado: (2022)

Tocilizumab and COVID-19: Timing of Administration and Efficacy
por: Abidi, Emna, et al.
Publicado: (2022)

Clinical Outcomes Following Tocilizumab Administration in Mechanically Ventilated Coronavirus Disease 2019 Patients
por: Sirimaturos, Michael, et al.
Publicado: (2020)

Tocilizumab: Acute terminal ileum and perforated caecal ulceration following off label use: case report
Publicado: (2020)

Tocilizumab in Large Vessel Vasculitis – Different Routes of Administration
por: Schmalzing, Marc, et al.
Publicado: (2018)

Impact of tocilizumab administration on mortality in severe COVID-19
por: Tsai, Andrew, et al.
Publicado: (2020)

Tocilizumab administration in a refractory case of COVID-19
por: Dastan, Farzaneh, et al.
Publicado: (2020)

Clinical effect of early administration of tocilizumab following the initiation of corticosteroid therapy for patients with COVID-19()
por: Kawamata, Takaya, et al.
Publicado: (2022)

Performance of the modified HEART score in an Asian population
por: Sajeed, Shanaz Matthew, et al.
Publicado: (2020)

Defining a clinical prediction rule to diagnose bacterial gastroenteritis requiring empirical antibiotics in an emergency department setting: A retrospective review
por: Sajeed, Shanaz Matthew, et al.
Publicado: (2023)

Stevens-Johnson Syndrome complicated by obstructive uropathy, pneumothorax, and pneumomediastinum: a case report and literature review
por: Bruce-Hickman, Damian, et al.
Publicado: (2019)

Tocilizumab administration in COVID-19 patients: Water on the fire or gasoline?
por: Deana, Cristian, et al.
Publicado: (2021)

Measurement of renal congestion and compliance following intravenous fluid administration using shear wave elastography()
por: Bruce-Hickman, Damian, et al.
Publicado: (2023)

Successful Use of Tocilizumab in a Patient with Coexisting Rheumatoid Arthritis and Ulcerative Colitis
por: Szeto, Matthew Chak Hin, et al.
Publicado: (2016)

Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients
por: Rutgers, Abraham, et al.
Publicado: (2022)

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
por: Pers, Yves-Marie, et al.
Publicado: (2011)

Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19
por: Gade, Akhil R., et al.
Publicado: (2020)

Administration Timing and Efficacy of Tocilizumab in Patients With COVID-19 and Elevated IL-6
por: Li, Pan, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of Subcutaneous Sarilumab and Intravenous Tocilizumab Following Single‐Dose Administration in Patients With Active Rheumatoid Arthritis on Stable Methotrexate
por: Paccaly, Anne J., et al.
Publicado: (2020)

Throat swelling following tocilizumab infusion—not always angioedema
por: Baenziger-Sieber, Patricia, et al.
Publicado: (2021)

Severe prolonged neutropenia following administration of tocilizumab in a patient affected by COVID-19: a case report and brief review of the literature
por: Bernardo, Luca, et al.
Publicado: (2020)

Tocilizumab: Anaphylaxis following off-label use: case report
Publicado: (2021)

Tocilizumab: Neutropenia following off-label use: case report
Publicado: (2021)

Predictors of the Outcomes Following the Tocilizumab Treatment for Severe COVID-19
por: Singla, Karan, et al.
Publicado: (2022)

Mr. Semple on the State of the Bowels in Ulcers
por: Semple, Robert
Publicado: (1813)

IMPROVED SURVIVAL OUTCOME IN PATIENTS WITH SARS-COV-2 (COVID-19) ARDS WITH TOCILIZUMAB ADMINISTRATION
por: Wadud, Nafisa, et al.
Publicado: (2020)

Comparative Efficacy of Tocilizumab and Baricitinib Administration in COVID-19 Treatment: A Retrospective Cohort Study
por: Kojima, Yuichi, et al.
Publicado: (2022)

Atypical Cogan's Syndrome Mimicking Giant Cell Arteritis Successfully Treated with Early Administration of Tocilizumab
por: Hara, Kazusato, et al.
Publicado: (2021)

Re: Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM
por: Klopfenstein, Timothée, et al.
Publicado: (2022)

ChatGPT versus human in generating medical graduate exam multiple choice questions—A multinational prospective study (Hong Kong S.A.R., Singapore, Ireland, and the United Kingdom)
por: Cheung, Billy Ho Hung, et al.
Publicado: (2023)

Tocilizumab: Invasive pulmonary aspergillosis following off-label use of tocilizumab for severe acute respiratory coronavirus-2 infection: case report
Publicado: (2021)

Exacerbation of Ulcerative Colitis with Tocilizumab: A Report of Two Cases, One with Takayasu Arteritis and the Other with Relapsing Polychondritis
por: Hanioka, Yusuke, et al.
Publicado: (2020)

Tocilizumab and COVID-19
por: Chaudhry, Dhruva, et al.
Publicado: (2020)

Drug-induced liver injury following the use of tocilizumab or sarilumab in patients with coronavirus disease 2019
por: Gao, Qian, et al.
Publicado: (2022)

Tocilizumab: Septic shock following off-label use: case report
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g2p4qen14jr0mj90jft50impse